Hikma Pharmaceuticals (LON:HIK) Shares Pass Above 200-Day Moving Average – Time to Sell?

Shares of Hikma Pharmaceuticals PLC (LON:HIK) passed above its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of GBX 1,990.43 ($25.05) and traded as high as GBX 2,320 ($29.19). Hikma Pharmaceuticals shares last traded at GBX 2,294 ($28.87), with a volume of 287,835 shares changing hands.

Wall Street Analyst Weigh In

Separately, Berenberg Bank upped their price target on shares of Hikma Pharmaceuticals from GBX 2,400 ($30.20) to GBX 2,560 ($32.21) and gave the company a “buy” rating in a research report on Wednesday, January 29th.

Hikma Pharmaceuticals Price Performance

The firm has a 50 day moving average price of GBX 2,104.66 and a 200 day moving average price of GBX 1,990.43. The stock has a market capitalization of £6.33 billion, a PE ratio of 22.39, a price-to-earnings-growth ratio of 2.38 and a beta of 0.41. The company has a current ratio of 1.66, a quick ratio of 1.27 and a debt-to-equity ratio of 55.82.

About Hikma Pharmaceuticals

At Hikma we help put better health within reach, every day. By creating high-quality medicines and making them accessible to the people who need them, we help to shape a healthier world that enriches all our communities. We help deliver this by living our culture, delivering our strategy, and acting responsibly.